Trial · NCT03201445
Results by group36
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 36
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Participants With a ≥ 50% Decrease From Baseline in Sperm Concentration at Week 13 | Filgotinib | 1.5 | percentage of participants | ||
| Percentage of Participants With a ≥ 50% Decrease From Baseline in Sperm Concentration at Week 13 | Placebo | 9.0 | percentage of participants | ||
| Percentage of Participants With a ≥ 50% Decrease From Baseline in Sperm Concentration at Week 26 | Filgotinib/DB Filgotinib (Responder) | 5.0 | percentage of participants | ||
| Percentage of Participants With a ≥ 50% Decrease From Baseline in Sperm Concentration at Week 26 | Filgotinib/OL Filgotinib (Nonresponder) | 0 | percentage of participants | ||
| Percentage of Participants With a ≥ 50% Decrease From Baseline in Sperm Concentration at Week 26 | Placebo/DB Placebo (Responder) | 7.9 | percentage of participants | ||
| Percentage of Participants With a ≥ 50% Decrease From Baseline in Sperm Concentration at Week 26 | Placebo/OL Filgotinib (Nonresponder) | 11.8 | percentage of participants | ||
| Change From Baseline in Sperm Total Motility at Week 13 | Filgotinib | -0.3 | 95% Confidence Interval -1.6 to 1.7 | percentage of motile sperms | |
| Change From Baseline in Sperm Total Motility at Week 13 | Placebo | 0.4 | 95% Confidence Interval -1.3 to 1.5 | percentage of motile sperms | |
| Change From Baseline in Sperm Total Motility at Week 26 | Filgotinib/DB Filgotinib (Responder) | -2.3 | 95% Confidence Interval -4.7 to -0.3 | percentage of motile sperms | |
| Change From Baseline in Sperm Total Motility at Week 26 | Filgotinib/OL Filgotinib (Nonresponder) | -1.5 | 95% Confidence Interval -5.8 to 2.6 | percentage of motile sperms | |
| Change From Baseline in Sperm Total Motility at Week 26 | Placebo/DB Placebo (Responder) | 0.0 | 95% Confidence Interval -3.4 to 2.4 | percentage of motile sperms | |
| Change From Baseline in Sperm Total Motility at Week 26 | Placebo/OL Filgotinib (Nonresponder) | 0.8 | 95% Confidence Interval -7.3 to 5.8 | percentage of motile sperms | |
| Change From Baseline in Total Sperm Count at Week 13 | Filgotinib | -11.6 | 95% Confidence Interval -19.8 to 9.7 | million sperm cells/ejaculate | |
| Change From Baseline in Total Sperm Count at Week 13 | Placebo | -9.5 | 95% Confidence Interval -23.8 to 0.6 | million sperm cells/ejaculate | |
| Change From Baseline in Total Sperm Count at Week 26 | Filgotinib/DB Filgotinib (Responder) | 2.0 | 95% Confidence Interval -19.6 to 17.2 | million sperm cells/ejaculate | |
| Change From Baseline in Total Sperm Count at Week 26 | Filgotinib/OL Filgotinib (Nonresponder) | -4.6 | 95% Confidence Interval -42.3 to 18.3 | million sperm cells/ejaculate | |
| Change From Baseline in Total Sperm Count at Week 26 | Placebo/DB Placebo (Responder) | -4.1 | 95% Confidence Interval -39.8 to 15.9 | million sperm cells/ejaculate | |
| Change From Baseline in Total Sperm Count at Week 26 | Placebo/OL Filgotinib (Nonresponder) | 12.7 | 95% Confidence Interval -61.4 to 40.8 | million sperm cells/ejaculate | |
| Change From Baseline in Sperm Concentration at Week 13 | Filgotinib | 1.0 | 95% Confidence Interval -2.2 to 3.9 | million sperm cells/mL | |
| Change From Baseline in Sperm Concentration at Week 13 | Placebo | 0.7 | 95% Confidence Interval -2.7 to 1.7 | million sperm cells/mL |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03201445/results